期刊
SEMINARS IN NEUROLOGY
卷 34, 期 2, 页码 160-173出版社
THIEME MEDICAL PUBL INC
DOI: 10.1055/s-0034-1381734
关键词
corticobasal degeneration; corticobasal syndrome; nonfluent progressive aphasia; frontotemporal dementia; progressive supranuclear palsy; tauopathy; atypical parkinsonian syndromes; neurodegeneration
资金
- NIA NIH HHS [R01 AG024040] Funding Source: Medline
Among the atypical parkinsonian syndromes, corticobasal degeneration (CBD) is probably the most challenging disorder to diagnose antemortem. It can present with multiple phenotypes, none of them specific enough to lead to an unequivocal diagnosis. Alternatively, multiple other neurodegenerative disorders with a different underlying pathology, such as Alzheimer disease (AD), can mimic its clinical course. The ultimate etiology of CBD is unknown; however, current neuropathological and genetic evidence support a role for microtubule-associated protein tau. The classic clinical presentation is corticobasal syndrome, which typically presents as an asymmetric parkinsonism with a variable combination of ideomotor apraxia, rigidity, myoclonus, and dystonia, often associated with the presence of an alien limb phenomenon. Recently, a new set of diagnostic criteria has been developed, but still definite diagnosis requires autopsy confirmation. At the present time, no disease modifying therapies are available, but extensive research is being conducted.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据